Neuropharmacological characterization of local ibogaine effects on dopamine release

Journal of Neural Transmission

Volumn 103, Issue 8-9, 1996, Pages 967-985

  Reid, M S ^a   Hsu Jr , K ^a   Souza, K H ^a   Broderick, P A ^b   Berger, S P ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

Cocaine; Dopamine; Dopamine transporter; Harmaline; Kappaopiate receptor; Nucleus accumbens; Reserpine; Striatum

Indexed keywords

CALCIUM; COCAINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HARMALINE; IBOGAINE; KAPPA OPIATE RECEPTOR; METIROSINE; NALOXONE; NORBINALTORPHIMINE; RESERPINE; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOSE RESPONSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; NERVE ENDING; NEUROPHARMACOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; IBOGAINE; MALE; MICRODIALYSIS; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 0029805893     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01291787     Document Type: Article

References (43)

1. Alexander GM, Grothusen JR, Schwartzman RJ (1988) Flow dependent changes in the effective surface area of microdialyis probes. Life Sci 43: 595-601
2. Bogdanski DF, Brodie BB (1969) The effects of inorganic ions on the storage and uptake H3-norepinephrine by rat heart slices. J Pharmacol Exp Ther 165: 181-189
3. Broderick PA (1987) Striatal neurochemistry of Dynorphin-(1-13): in vivo electrochemical semi-differential analysis. Neuropeptides 10: 369-386
4. Broderick PA, Phelan FT, Eng F, Wechsler RT (1994) Ibogaine modulates cocaine responses which are altered due to environmental habituation: in vivo microvoltammetric and behavioral studies. Pharmacol Biochem Behav 49: 711-728
5. Cappendijk SLT, Dzoljic MR (1993) Inhibitory effects of ibogaine on cocaine self-administration in rats. Eur J Pharmacol 241: 261-265
6. Carboni E, Imperato A, Perezanni L, DiChiara G (1991) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28: 653-661
7. Crawford CA, McDougall SA, Bolanos CA, Hall S, Berger SP (1995) The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. Psychopharm 120: 392-399
8. Deecher DC, Teitler M, Soderlund DM, Bornmann WG, Kuehne ME, Glick SD (1992) Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Res 571: 242-247
9. Drucker G, Raikoff K, Neafsey NJ, Collins MA (1990) Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) oxidation products. Brain Res 509: 125-133
10. Fischer JF, Cho AK (1979) Chemical release of dopamine from caudate-putamen homogenate: evidence for an exhange diffusion model. J Pharmacol Exp Ther 208: 203-209
11. Florin SM, Kuczenski R, Segal DS (1995) Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral consideration. J Pharmacol Exp Ther 274: 231-241
12. Fujise H, Hamada Y, Mori M, Ochiai H (1995) Na-dependent glutamate transport in high K and High glutathione (HK/HG) and high L low glutathione (HK/LG) dog red blood cells. Biochem Biophys Acta 1239: 22-26
13. Glick SD, Rossman K, Steindorf S, Maisonneuve IM, Carlson JN (1991) Effects and aftereffects of ibogaine on morphine self-administration in rats. Eur J Pharmacol 195: 341-345
14. Glick SD, Rossman K, Wang S, Dong N, Keller Jr RW (1993) Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with d-amphetamine. Brain Res 628: 201-208
15. Harsing Jr LG, Sershen H, Lajtha A (1994) Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum. J Neural Transm [Gen Sect] 96: 215-225
16. Heidbreder CA, Goldberg SR, Shippenberg TS (1993) The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res 616: 335-338
17. Hernandez L, Hoebel BG (1988) Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Life Sci 42: 1,702-1,705
18. Hurd YL, Ungerstedt U (1989a) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur J Pharmacol 166: 251-260
19. +. Life Sci 45: 283-293
20. Janowsky A, Berger SP, Vocci F, Labarca R, Skolnick P, Paul SM (1986) Characterization of sodium dependent [3H]-GBR 12935 binding in brain: a radioligand for selection labeling of the dopamine transport complex. J Neurochem 46: 1,274-1,276
21. King SM, Tunnicliff G (1990) Na(+)- and Cl(-)-dependent [3H]GABA binding to catfish brain brain particles. Biochem Intl 20: 821-831
22. Kscha U, Farber SA, Marshall D, Wurtman RJ (1993) Carbachol and naloxone synergistically elevate dopamine release in rat striatum: an in vivo microdialysis study. Brain Res 613: 288-290
23. Lindefors N, Amberg G, Ungerstedt U (1989) Intracerbral microdialysis. I. Experimental studies of diffusion kinetics. J Pharmacol Meth 22: 141-156
24. Maisonneuve IM, Glick SD (1992) Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior. Eur J Pharmacol 212: 263-266
25. Maisonneuve IM, Keller Jr RW, Glick SD (1991) Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. Eur J Pharmacol 199: 35-42
26. Maisonneuve IM, Keller Jr RW, Glick SD (1992) Interactions of ibogaine and d-amphetamine: in vivo microdialysis and motor behavior in rats. Brain Res 579: 87-92
27. Maisonneuve IM, Archer S, Glick SD (1994) U50,488 a kappa opioid agonist attenuates cocaine induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett 181: 57-60
28. Mash DC, Staley JK, Baumann MH, Rothman RB, Hearn WL (1995) Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. Life Sci 57: PL45-PL50
29. McMillen BA, German DC, Shore PA (1980) Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. Biochem Pharmacol 29: 3,045-3,050
30. Newman EA (1991) Sodium-bicarbonate cotransport in retinal Muller (glial) cells of the salamander. J Neurosci 11: 3,972-3,983
31. Osborne PG, O'Connor WT, Drew KL, Ungerstedt U (1990) An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake, freely moving and halothane anaesthetized rats. J Neurosci Meth 34: 99-105
32. Paton DM (1973) Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria. Br J Pharmacol 49: 614-627
33. Pearl SM, Herrick-Davis K, Teitler M, Glick SD (1995) Radioligand binding study of noribogaine, a likely metabolite of ibogaine. Brain Res 675: 342-344
34. Popik P, Layer RT, Skolnick P (1994) The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]-MK-801 binding to the NMDA receptor complex. Psychopharm 114: 672-674
35. Sershen H, Hashim A, Harsing L, Abel L (1992) Ibogaine antagonizes cocaine-induced locomotor stimulation in mice. Life Sci 50: 1,079-1,086
36. Sershen H, Hashim, Lajtha A (1995) The effect of ibogaine on kappa-opioid and 5-HT3-induced changes in stimulation evoked dopamine release in vitro from striatum of C57BL/6By mice. Brain Res Bull 36: 587-591
37. Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55: 1,734-1,740
38. Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89: 2,046-2,050
39. Spealman RD, Bergman J (1992) Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 261: 607-615
40. Stahle L, Segersvard S, Ungerstedt U (1991) A comparison between three methods for estimation of extracellular concentrations of exongenous and endogenous compounds by microdialysis. J Pharmacol Meth 25: 41-52
41. Suzuki T, Shiozaki Y, Masukawa Y, Misawa M, Nagase H (1992) The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn J Pharmacol 58: 435-442
42. Sweetnam PM, Lancaster J, Snowman A, Collins JL, Perschke S, Bauer C, Ferkany J (1995) Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity. Psychopharm 118: 369-376
43. Van Winkle LJ, Campione AL, Mann DF, Wasserlauf HG (1993) The cation receptor subsite of the choline transporter in preimplation mause conceptus resembles a cation receptor subsite of several amino acid transporters. Biochim Biophys Acta 1146: 38-44